Annual Net Income
-$12.47 M
+$1.50 M+10.72%
31 December 2023
Summary:
NeuroBo Pharmaceuticals annual net profit is currently -$12.47 million, with the most recent change of +$1.50 million (+10.72%) on 31 December 2023. During the last 3 years, it has risen by +$2.81 million (+18.41%). NRBO annual net income is now -3796.88% below its all-time high of -$320.00 thousand, reached on 31 December 2014.NRBO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$5.65 M
+$4.40 M+43.78%
30 September 2024
Summary:
NeuroBo Pharmaceuticals quarterly net profit is currently -$5.65 million, with the most recent change of +$4.40 million (+43.78%) on 30 September 2024. Over the past year, it has dropped by -$338.00 thousand (-6.36%). NRBO quarterly net income is now -226.95% below its all-time high of $4.45 million, reached on 31 December 2018.NRBO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$27.73 M
-$1.83 M-7.08%
30 September 2024
Summary:
NeuroBo Pharmaceuticals TTM net profit is currently -$27.73 million, with the most recent change of -$1.83 million (-7.08%) on 30 September 2024. Over the past year, it has dropped by -$15.26 million (-122.40%). NRBO TTM net income is now -1116.89% below its all-time high of -$2.28 million, reached on 31 March 2015.NRBO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRBO Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -6.4% | -122.4% |
| 3 y3 years | +18.4% | -23.5% | -81.5% |
| 5 y5 years | +41.5% | +57.6% | -30.1% |
NRBO Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +18.4% | -670.0% | +43.8% | -149.2% | at low |
| 5 y | 5 years | at high | +58.0% | -670.0% | +71.0% | -149.2% | +8.2% |
| alltime | all time | -3796.9% | +62.7% | -226.9% | +71.0% | -1116.9% | +18.1% |
NeuroBo Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.65 M(-43.8%) | -$27.73 M(+7.1%) |
| June 2024 | - | -$10.05 M(+49.7%) | -$25.90 M(+56.2%) |
| Mar 2024 | - | -$6.71 M(+26.3%) | -$16.58 M(+33.0%) |
| Dec 2023 | -$12.47 M(-10.7%) | -$5.31 M(+39.2%) | -$12.47 M(+5.4%) |
| Sept 2023 | - | -$3.82 M(+420.2%) | -$11.83 M(+6.3%) |
| June 2023 | - | -$734.00 K(-71.8%) | -$11.13 M(-18.8%) |
| Mar 2023 | - | -$2.60 M(-44.3%) | -$13.70 M(-1.9%) |
| Dec 2022 | -$13.97 M(-8.6%) | -$4.68 M(+50.2%) | -$13.97 M(+0.7%) |
| Sept 2022 | - | -$3.11 M(-5.8%) | -$13.87 M(-2.4%) |
| June 2022 | - | -$3.30 M(+14.9%) | -$14.22 M(-4.2%) |
| Mar 2022 | - | -$2.88 M(-37.2%) | -$14.84 M(-2.9%) |
| Dec 2021 | -$15.28 M(-48.5%) | -$4.58 M(+32.3%) | -$15.28 M(-49.4%) |
| Sept 2021 | - | -$3.46 M(-11.7%) | -$30.22 M(+1.4%) |
| June 2021 | - | -$3.92 M(+18.0%) | -$29.81 M(+5.4%) |
| Mar 2021 | - | -$3.32 M(-83.0%) | -$28.27 M(-4.7%) |
| Dec 2020 | -$29.68 M(+39.3%) | -$19.51 M(+538.8%) | -$29.68 M(+26.3%) |
| Sept 2020 | - | -$3.05 M(+28.1%) | -$23.49 M(-2.4%) |
| June 2020 | - | -$2.38 M(-49.6%) | -$24.06 M(+2.0%) |
| Mar 2020 | - | -$4.73 M(-64.5%) | -$23.58 M(+10.6%) |
| Dec 2019 | -$21.31 M | -$13.33 M(+268.0%) | -$21.31 M(+503.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$3.62 M(+90.5%) | -$3.53 M(-41.0%) |
| June 2019 | - | -$1.90 M(-22.8%) | -$5.99 M(-44.4%) |
| Mar 2019 | - | -$2.46 M(-155.3%) | -$10.77 M(-30.7%) |
| Dec 2018 | -$15.53 M(-53.5%) | $4.45 M(-173.2%) | -$15.53 M(-41.9%) |
| Sept 2018 | - | -$6.08 M(-9.0%) | -$26.73 M(-8.8%) |
| June 2018 | - | -$6.68 M(-7.6%) | -$29.32 M(-11.5%) |
| Mar 2018 | - | -$7.22 M(+7.1%) | -$33.14 M(-0.8%) |
| Dec 2017 | -$33.41 M(+129.1%) | -$6.75 M(-22.2%) | -$33.41 M(-1.4%) |
| Sept 2017 | - | -$8.67 M(-17.4%) | -$33.88 M(+16.5%) |
| June 2017 | - | -$10.50 M(+40.1%) | -$29.09 M(+45.6%) |
| Mar 2017 | - | -$7.50 M(+3.9%) | -$19.98 M(+37.0%) |
| Dec 2016 | -$14.59 M(+61.5%) | -$7.21 M(+86.0%) | -$14.59 M(+46.7%) |
| Sept 2016 | - | -$3.88 M(+178.8%) | -$9.94 M(+15.2%) |
| June 2016 | - | -$1.39 M(-33.9%) | -$8.63 M(-2.5%) |
| Mar 2016 | - | -$2.10 M(-18.2%) | -$8.85 M(-1.9%) |
| Dec 2015 | -$9.03 M(+2721.6%) | -$2.57 M(+0.0%) | -$9.03 M(+39.8%) |
| Sept 2015 | - | -$2.57 M(+59.5%) | -$6.46 M(+66.0%) |
| June 2015 | - | -$1.61 M(-29.3%) | -$3.89 M(+70.7%) |
| Mar 2015 | - | -$2.28 M | -$2.28 M |
| Dec 2014 | -$320.00 K | - | - |
FAQ
- What is NeuroBo Pharmaceuticals annual net profit?
- What is the all time high annual net income for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly net income year-on-year change?
- What is NeuroBo Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals TTM net income year-on-year change?
What is NeuroBo Pharmaceuticals annual net profit?
The current annual net income of NRBO is -$12.47 M
What is the all time high annual net income for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual net profit is -$320.00 K
What is NeuroBo Pharmaceuticals quarterly net profit?
The current quarterly net income of NRBO is -$5.65 M
What is the all time high quarterly net income for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly net profit is $4.45 M
What is NeuroBo Pharmaceuticals quarterly net income year-on-year change?
Over the past year, NRBO quarterly net profit has changed by -$338.00 K (-6.36%)
What is NeuroBo Pharmaceuticals TTM net profit?
The current TTM net income of NRBO is -$27.73 M
What is the all time high TTM net income for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high TTM net profit is -$2.28 M
What is NeuroBo Pharmaceuticals TTM net income year-on-year change?
Over the past year, NRBO TTM net profit has changed by -$15.26 M (-122.40%)